• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Oral Anticoagulation: Would You Recognize a Candidate?

Poll

What does the patient with atrial fibrillation who would benefit from oral anticoagulation look like today? Q & A, here.

The “face” of the patient with atrial fibrillation (AF) who will benefit from some level of anticoagulation therapy is changing. The most recent change in look is a result of updated guidelines put forth by the American Heart Association, American College of Cardiology, and Heart Rhythm Society in 2014.

Which of the following are current guideline recommendations for oral anticoagulation in patients with atrial fibrillation?

A. Use oral anticoagulation in male patients with CHA2DS2-VASc score ≥1 and female patients with a score ≥2.
B. Use oral anticoagulation in CHA2DS2-VASc stroke risk score ≥2 for patients of both sexes.
C. Use oral anticoagulation in CHA2DS2 stroke risk score ≥2 for patients of both sexes.
D. All of the above
Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2024 MJH Life Sciences

All rights reserved.